María Pellecchia L, Manuel Correa FJ. Comparison of clinical efficacy and dosing regimens between Nirsevimab and Palivizumab for prophylaxis against RSV in the pediatric population. SAP Primary Care. 2025;1:18. doi:10.62486/pc202518